The Science of Ultrasound Renal Denervation
Why use ultrasound for Renal Denervation (RDN)?
The Science of Ultrasound Renal Denervation brings together four experts to introduce ultrasound renal denervation technology. This one-hour educational program walks you through the core concepts and the pre-clinical evidence used to refine the design that led to the ultrasound renal denervation technology.
If you have watched the on-demand video we would be most grateful if you could complete a short survey. To take part please click HERE
This webinar is supported by
16:00 - 16:05
Introduction of ultrasound renal denervation technology
Prof Philipp Lurz
16:05 - 16:15
Ultrasound technology - its development and unique characteristics
Mr Andrew Wu
16:15 - 16:30
Pre-clinical evidence (Histopathology)
Prof Michael Joner
16:30 - 16:45
RDN procedure with ultrasound technology
Prof Felix Mahfoud
16:45 - 17:00
Panel discussion and closing remarks
- Understand the mechanism of action of ultrasound denervation technology
- Learn the scientific rationales behind the design of ultrasound technology for RDN
- Learn the pre-clinical evidence and histopathology of ultrasound renal denervation
- Hear expert discussions and takeaways
- Interventional Cardiologists
- Hypertension Specialists
- Primary Care Physicians
- General Cardiologists
Prof Philipp Lurz is Deputy Head of the Department at Heart Center Leipzig, Germany, a position he has held since 2018. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Philipp is widely published in leading international peer-reviewed journals.
Dr Michael Joner MD completed his medical training at the University of Wuerzburg and spent 2004-2006 as a cardiovascular pathology fellow at the CVPath Institute.
After returning to Germany, since 2007 Dr Joner has been Head of the Preclinical Research at the German Heart Centre in Munich, where he also completed his interventional cardiology residency.
Prof Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital, and Affiliate/Visiting Professor Harvard-MIT Biomedical Engineering, Institute of Medical Engineering and Science, Cambridge, US. Prof Mahfoud completed training in Cardiology and Interventional Cardiology at the Department for Internal Medicine III, Saarland University Hospital, Germany in 2014. Since 2017, he has served as Vice Chairman of the ‘Working Group on Interventional Hypertension Treatment’ for the European Society of Hypertension, and as a Committee Member of the 2018 Hypertension Guidelines.
Former Vice President, Research & Development, ReCor Medical
Mr Wu has over 20 years of experience in medical device product development. He has worked on devices in the fields of interventional cardiology, electrophysiology, pulmonology, and women’s health, and has taken a number of them from early concept phase through clinical or commercial launch.